Involvement of clusterin in 15-deoxy-Δ12,14-prostaglandin J2-induced vascular smooth muscle cell differentiation

Biochemical and Biophysical Research Communications

Volumn 319, Issue 1, 2004, Pages 163-168

  Miwa, Yoshikazu ^a   Takahashi Yanaga, Fumi ^a   Morimoto, Sachio ^a   Sasaguri, Toshiyuki ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CLUSTERIN; GLYCOPROTEIN; MESSENGER RNA; PROSTAGLANDIN J2;

APOPTOSIS; ARTICLE; CELL ACTIVITY; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; MOLECULAR DYNAMICS; MOLECULAR INTERACTION; MOLECULAR MECHANICS; NODULATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; STATISTICAL SIGNIFICANCE; VASCULAR SMOOTH MUSCLE;

APOPTOSIS; BLOTTING, WESTERN; CELL DIFFERENTIATION; CELL NUCLEUS; CELLS, CULTURED; CLUSTERIN; GLYCOPROTEINS; HUMANS; MOLECULAR CHAPERONES; MUSCLE, SMOOTH; MUSCLE, SMOOTH, VASCULAR; PROSTAGLANDIN D2; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TIME FACTORS; UMBILICAL VEINS;

EID: 2442718691     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2004.04.163     Document Type: Article

References (34)

1. Ross R. The pathogenesis of atherosclerosis. Nature. 362:1993;801-809. (Review)
2. Nagy L., Tontonoz P., Alvarez J.G.A., Chen H., Evans R.M. Oxidized LDL regulates macrophage gene expression through ligand activation of PPARγ Cell. 93:1998;229-240
3. Tontonoz P., Nagy L., Alvarez J.G.A., Thomazy V.A., Evans R.M. PPARγ promotes monocyte/macrophage differentiation and uptake of oxidized LDL. Cell. 93:1998;241-252
4. Ricote M., Li A.C., Willson T.M., Kelly C.J., Glass C.K. The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation. Nature. 39:1998;179-182
5. Jiang C., Ting A.T., Seed B. PPAR-γ agonists inhibit production of monocyte inflammatory cytokines. Nature. 391:1998;82-86
6. Marx N., Sukhova G., Murphy C., Libby P., Plutzky J. Macrophages in human atheroma contain PPARγ: differentiation-dependent peroxisomal proliferator-activated receptor γ (PPARγ) expression and reduction of MMP-9 activity through PPARγ activation in mononuclear phagocytes in vitro. Am. J. Pathol. 153:1998;17-23
7. 2 synthase expression in vascular endothelial cells. Circ. Res. 86:2000;967-973
8. 1 arrest and differentiation marker expression in vascular smooth muscle cells Mol. Pharmacol. 58:2000;837-844
9. Owens G.K. Regulation of differentiation of vascular smooth muscle cells. Physiol. Rev. 75:1995;487-517
10. Waf1/Cip1/Sdi1 in vascular smooth muscle cells. Mol. Pharmacol. 56:1999;938-946
11. Blank R.S., Thompson M.M., Owens G.K. Cell cycle versus density dependence of smooth muscle alpha actin expression in cultured rat aortic smooth muscle cells. J. Cell Biol. 107:1988;299-306
12. Thomas-Salgar S., Millis A.J. Clusterin expression in differentiating smooth muscle cells. J. Biol. Chem. 269:1994;17879-17885
13. Moulson C.L., Millis A.J. Clusterin (Apo J) regulates vascular smooth muscle cell differentiation in vitro. J. Cell. Physiol. 180:1999;355-364
14. Millis A.J., Luciani M., McCue H.M., Rosenberg M.E., Moulson C.L. Clusterin regulates vascular smooth muscle cell nodule formation and migration. J. Cell. Physiol. 186:2001;210-219
15. Cervellera M., Raschella G., Santilli G., Tanno B., Ventura A., Mancini C., Sevignani C., Calabretta B., Sala A. Direct transactivation of the anti-apoptotic gene apolipoprotein J (clusterin) by B-MYB. J. Biol. Chem. 275:2000;21055-21060
16. Nagai R., Kuro-o M., Babij P., Periasamy M. Identification of two types of smooth muscle myosin heavy chain isoforms by cDNA cloning and immunoblot analysis. J. Biol. Chem. 264:1989;9734-9737
17. Babij P., Periasamy M. Myosin heavy chain isoform diversity in smooth muscle is produced by differential RNA processing. J. Mol. Biol. 210:1989;673-679
18. Aikawa M., Sivam P.N., Kuro-o M., Kimura K., Nakahara K., Takewaki S., Ueda M., Yamaguchi H., Yazaki Y., Periasamy M., Nagai R. Human smooth muscle myosin heavy chain isoforms as molecular markers for vascular development and atherosclerosis. Circ. Res. 73:1993;1000-1012
19. Aikawa M., Sakomura Y., Ueda M., Kimura K., Manabe I., Ishiwata S., Komiyama N., Yamaguchi H., Yazaki Y., Nagai R. Redifferentiation of smooth muscle cells after coronary angioplasty determined via myosin heavy chain expression. Circulation. 96:1997;82-90
20. Arens Y., Chapados R.A., Cox B.E., Kamm K.E., Rosenfeld C.R. Differential development of umbilical and systemic arteries II: contractile proteins. Am. J. Physiol. 274:1998;R1815-R1823
21. Haller H., Lindschau C., Quass P., Distler A., Luft F.C. Differentiation of vascular smooth muscle cells and the regulation of protein kinase C-alpha. Circ. Res. 76:1995;21-29
22. Reusch P., Wagdy H., Reusch R., Wilson E., Ives H.E. Mechanical strain increases smooth muscle and decreases nonmuscle myosin expression in rat vascular smooth muscle cells. Circ. Res. 79:1996;1046-1053
23. 1 growth inhibition of cultured vascular smooth muscle cells. Biochem. Biophys. Res. Commun. 239:1997;889-894
24. 1 arrest and differentiation of vascular smooth muscle cells. Circ. Res. 86:2000;68-75
25. Brennan M.J., Millis A.J., Fritz K.E. Fibronectin inhibits morphological changes in cultures of vascular smooth muscle cells. J. Cell. Physiol. 112:1982;284-290
26. Brennan M.J., Millis A.J., Mann D., Fritz K. Structural alterations in fibronectin correlated with morphological changes in smooth muscle cells. Dev. Biol. 97:1983;391-397
27. Hara I., Miyake H., Gleave M.E., Kamidono S. Introduction of clusterin gene into human renal cell carcinoma cells enhances their resistance to cytotoxic chemotherapy through inhibition of apoptosis both in vitro and in vivo. Jpn. J. Cancer Res. 92:2001;1220-1224
28. Miyake H., Nelson C., Rennie P.S., Gleave M.E. Testosterone-repressed prostate message-2 is an antiapoptotic gene involved in progression to androgen independence in prostate cancer. Cancer Res. 60:2000;170-176
29. Miyake H., Nelson C., Rennie P.S., Gleave M.E. Acquisition of chemoresistant phenotype by overexpression of the antiapoptotic gene testosterone-repressed prostate message-2 in prostate cancer xenograft models. Cancer Res. 60:2000;2547-2554
30. Miyake H., Hara I., Kamidono S., Gleave M.E. Synergistic chemsensitization and inhibition of tumor growth and metastasis by the antisense oligodeoxynucleotide targeting clusterin gene in a human bladder cancer model. Clin. Cancer Res. 7:2001;4245-4252
31. Zellweger T., Miyake H., July L.V., Akbari M., Kiyama S., Gleave M.E. Chemosensitization of human renal cell cancer using antisense oligonucleotides targeting the antiapoptotic gene clusterin. Neoplasia. 3:2001;360-367
32. Bach U.C., Baiersdorfer M., Klock G., Cattaruzza M., Post A., Koch-Brandt C. Apoptotic cell debris and phosphatidylserine-containing lipid vesicles induce apolipoprotein J (clusterin) gene expression in vital fibroblasts. Exp. Cell Res. 265:2001;11-20
33. Urbich C., Fritzenwanger M., Zeiher A.M., Dimmeler S. Laminar shear stress upregulates the complement-inhibitory protein clusterin: a novel potent defense mechanism against complement-induced endothelial cell activation. Circulation. 101:2000;352-355
34. Hirawa N., Uehara Y., Yamakado M., Toya Y., Gomi T., Ikeda T., Eguchi Y., Takagi M., Oda H., Seiki K., Urade Y., Umemura S. Lipocalin-type prostaglandin D synthase in essential hypertension. Hypertension. 39:2002;449-454